Hemodynamic changes induced by urinary human chorionic gonadotropin and recombinant luteinizing hormone used for inducing final follicular maturation and luteinization

Fertility and Sterility

Volumn 78, Issue 6, 2002, Pages 1261-1267

  Manau, Dolors ^a   Fábregues, Francisco ^a   Arroyo, Vicente ^a   Jiménez, Wladimiro ^a   Vanrell, Juan A ^a   Balasch, Juan ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

hCG; IVF; OHSS; Recombinant human LH

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; HEART OUTPUT; HEMODYNAMIC PARAMETERS; HUMAN; HYPOPHYSIS; LUTEINIZATION; MEAN ARTERIAL PRESSURE; MENSTRUAL CYCLE; NORADRENALIN BLOOD LEVEL; OVARY FOLLICLE MATURATION; OVULATION; PLASMA RENIN ACTIVITY; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; UNIVERSITY HOSPITAL; VASCULAR RESISTANCE;

CHORIONIC GONADOTROPIN; FEMALE; FERTILIZATION IN VITRO; HEMODYNAMIC PROCESSES; HUMANS; LUTEAL PHASE; LUTEINIZATION; LUTEINIZING HORMONE; NEUROTRANSMITTER AGENTS; OVARIAN FOLLICLE; PREGNANCY; PREGNANCY RATE; PROGESTERONE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; VASCULAR RESISTANCE;

EID: 0036901604     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)04394-7     Document Type: Article

References (19)

1. Barbieri R.L., Hornstein M.D. Assisted reproduction-in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues. Endocr Rev. 20:1999;249-252.
2. Whelan J.G., Vlahos N.F. The ovarian hyperstimulation syndrome. Fertil Steril. 73:2000;883-896.
3. Porchet H.C., Le Cotonnec J.Y., Neuteboom B., Canali S., Zanolo G. Pharmacokinetics of recombinant human luteinizing hormone after intravenous, intramuscular, and subcutaneous administration in monkeys and comparison with intravenous administration of pituitary human luteinizing hormone. J Clin Endocrinol Metab. 80:1995;667-673.
4. Le Cotonnec J.Y., Porchet H.C., Beltrami V., Munafo A. Clinical pharmacology of recombinant human luteinizing hormone Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone . Fertil Steril. 69:1998;189-194.
5. Le Cotonnec J.Y., Porchet H.C., Beltrami V., Munafo A. Clinical pharmacology of recombinant human luteinizing hormone Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay . Fertil Steril. 69:1998;195-200.
6. Peinado J.A., Molina I., Pla M., Tresguerres J.A.F., Romeu A. Recombinant-human luteinizing hormone (r-hLH) as ovulatory stimulus in superovulated does. J Assist Reprod Genet. 12:1995;61-64.
7. Recombinant human luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures results of a multicenter double-blind study . J Clin Endocrinol Metab. 86:2001;2607-2618.
8. Balasch J., Arroyo V., Carmona F., Llach J., Jimenez W., Pare J.C., et al. Severe ovarian hyperstimulation syndrome role of peripheral vasodilation . Fertil Steril. 56:1991;1077-1083.
9. Balasch J., Arroyo V., Fabregues F., Salo J., Jimenez W., Pare J.C., et al. Neurohormonal and hemodynamic changes in severe cases of the ovarian hyperstimulation syndrome. Ann Intern Med. 121:1994;27-33.
10. Balasch J., Fabregues F., Arroyo V. Peripheral arterial vasodilation hypothesis a new insight into the pathogenesis of ovarian hyperstimulation syndrome . Hum Reprod. 13:1998;2718-2730.
11. Evbuomwan I.O., Davison J.M., Murdoch A.P. Coexistent hemoconcentration and hypoosmolality during superovulation and in severe ovarian hyperstimulation syndrome a volume homeostasis paradox . Fertil Steril. 74:2000;67-72.
12. Manau D., Balasch J., Arroyo V., Jimenez W., Fabregues F., Casamitjana R., et al. Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators. J Clin Endocrinol Metab. 83:1998;1489-1493.
13. Manau D., Arroyo V., Jimenez W., Fabregues F., Vanrell J.A., Balasch J. Chronology of hemodynamic changes in asymptomatic in vitro fertilization patients and relationship with ovarian steroids and cytokines. Fertil Steril. 77:2002;1178-1183.
14. Veeck L.L. An atlas of human gametes and conceptuses. 1999;Parthenon, New York.
15. Golan A., Ron-El R., Herman A., Weinraub Z., Soffer Y., Caspi E. Ovarian hyperstimulation syndrome an update review . Obstet Gynecol Surv. 44:1989;430-440.
16. Schrier R.W. Body fluid volume regulation in health and disease a unifying hypothesis . Ann Intern Med. 113:1990;155-159.
17. Rizk B., Aboulghar M., Smitz J., Ron-El R. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Hum Reprod Update. 3:1997;255-266.
18. Pellicer A., Albert C., Mercader A., Bonilla-Musoles F., Remohi J., Simon C. The pathogenesis of ovarian hyperstimulation syndrome in vivo studies investigating the role of interleukin-1β, interleukin-6, and vascular endothelial growth factor . Fertil Steril. 71:1999;482-489.
19. Molina I., Santana A.G., Pla M., Romeu A. Induction of ovulation in rabbits by pure urinary luteinizing hormone. Hum Reprod. 9:1994;413-416.